CORONA - COVMon - Monitoring concepts for SARS-CoV-2 - epidemiology and co-infections; subproject 3
- Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
- Total publications:0 publications
Grant number: 03COV16C
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$637,851.73Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)Principal Investigator
Petra GastmeierResearch Location
GermanyLead Research Institution
Charité - Universitätsmedizin BerlinResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
Data Management and Data Sharing
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
COVID-19 Patients in intensive care units (ITS) often need mechanical ventilation or even receive extracorporeal membrane oxygenation (ECMO) or extracorporeal lung assist (ECLA) procedures. These applications, together with the other invasive device applications on ITS (urinary tract catheters, vascular catheters) could lead to a high risk for nosocomial infections, but also multidrug-resistant pathogens (MRE) during the stay on the ITS. Currently, however, there is no system to record such NI and MRE systematically and in a uniform structure on a larger number of ITS in COVID-19 patients. In COVMon-TV3, a surveillance system for NI/MRE in COVID-19 ITS patients will be developed and applied. The data obtained will be used to calculate epidemiological characteristics. These data will be made available to the participating ITS in a suitable form together with reference data (feedback) and can thus be used for internal quality management. In addition, an analysis of the NI and MRE data in comparison to other ITS patients is to be carried out in order to be able to describe and present the risk for NI and MRE of COVID-19 patients to non-COVID-19 patients on ITS.